PILOT STUDY ON THE EFFECTIVENESS OF CHOLINE ALFOSCERATE IN THE UNDER THRESHOLD DEPRESSION OF THE ELDERLY - n.a.

Azienda Socio Sanitaria Territoriale di Lodi0 个研究点目标入组 20 人开始时间: 2021年10月18日最近更新: 2023年9月11日

试验速览

暂无简介。

•1.Age = 65 years
•2.From 2 to 4 depressive symptoms present for at least two weeks prior to enrollment (Judd et al., 1994)
•3.Mini-Mental State Examination (MMSE) score = 24
•4.Montreal Cognitive Assessment (MOCA) score < 26
•5.Patients able to understand and sign informed consent
•6.Informed consent signature
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 20

•1.Any contraindication to treatment or intolerance to choline alfoscerate
•2.Diagnosis of Major Depressive Episode or Dysthymia
•3.Diagnosis of Schizophrenia or other psychotic disorders, Bipolar Disorder or Dementia
•4.Alcohol / drug / substance abuse or dependence
•5.Severe organic disease (eg major surgery, metastatic cancer, stroke, severe neurological disorder, myocardial infarction, chronic heart failure)
•6.Treatment with antidepressants or psychotherapy within 2 weeks prior to recruitment
•7.Any condition which, in the opinion of the investigator, might put the patient at risk by participation in this study
•8.Patients involved in other clinical trials

发起方